
Federal Circuit overturns 9.1 million dollar fee award in vitamin patent case
The U.S. Court of Appeals for the Federal Circuit reversed a district court order requiring ChromaDex to pay 9.1 million dollars in legal fees to rival Elysium Health. The decision settles an exceptional-case dispute over dietary supplement intellectual property licensed from Dartmouth College. Judges ruled that while ChromaDex lost on patent eligibility, its arguments were neither frivolous nor foreclosed by Supreme Court precedent.
Giovanni Sapere















